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ABSTRACT 
Biomarkers are nowadays essential tools to be one step ahead for fighting disease, 
enabling an enhanced focus on disease prevention and on the probability of its 
occurrence. Research in a multidisciplinary approach has been an important step 
towards the repeated discovery of new biomarkers.  
Biomarkers are defined as biochemical measurable indicators of the presence of disease 
or as indicators for monitoring disease progression. Currently, biomarkers have been 
used in several domains such as oncology, neurology, cardiovascular, inflammatory and 
respiratory disease, and several endocrinopathies.  Bridging biomarkers in a One Health 
perspective has been proven useful in almost all of these domains.  
In oncology, humans and animals are found to be subject to the same environmental and 
genetic predisposing factors: examples include the existence of mutations in BR-CA1 
gene predisposing to breast cancer, both in human and dogs, with increased prevalence 
in certain dog breeds and human ethnic groups. Also, breast feeding frequency and 
duration has been related to a decreased risk of breast cancer in women and bitches.  
When it comes to infectious diseases, this parallelism is prone to be even more 
important, for as much as 75% of all emerging diseases are believed to be zoonotic. 
Examples of successful use of biomarkers have been found in several zoonotic diseases 
such as Ebola, dengue, leptospirosis or West Nile virus infections. 
Acute Phase Proteins (APPs) have been used for quite some time as biomarkers of 
inflammatory conditions. These have been used in human health but also in the 
veterinary field such as in mastitis evaluation and PRRS (porcine respiratory and 
reproductive syndrome) diagnosis. Advantages rely on the fact that these biomarkers 
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can be much easier to assess than other conventional disease diagnostic approaches 
(example: measured in easy to collect saliva samples).  
Another domain in which biomarkers have been essential is food safety: the possibility 
to measure exposure to chemical contaminants or other biohazards present in the food 
chain, which are sometimes analytical challenges due to their low bioavailability in 
body fluids, is nowadays a major breakthrough.  
Finally, biomarkers are considered the key to provide more personalized therapies, with 
more efficient outcomes and fewer side effects. This approach is expected to be the 
correct path to follow also in veterinary medicine, in the near future.  
